Key Facts
• August 5, 2025: U.S. halts $500 million mRNA vaccine funding.
• 22 projects, including those by Pfizer and Moderna, are affected.
• Funds were aimed at combating influenza, COVID-19, and avian flu.
• Health Secretary Robert F. Kennedy Jr. cited higher risks than benefits for mRNA technology.
• Kennedy plans to redirect funds to safer, more versatile vaccine platforms.
• Experts warn this decision may hinder future pandemic preparedness.
• FDA ex-official Peter Lurie emphasized mRNA vaccines’ role in saving millions of lives.
• Paul Offit, a pediatrician, called mRNA vaccines “remarkably safe” and vital for severe infections.
• Kennedy dismissed CDC’s COVID-19 vaccine recommendations for children and pregnant women.
• June 2025: Kennedy replaced all 17 advisory committee members on vaccination policies.
Summary
The U.S. Department of Health and Human Services announced on August 5, 2025, the termination of $500 million in funding for mRNA vaccine development. This decision impacts 22 projects led by major pharmaceutical companies like Pfizer and Moderna, targeting viruses such as influenza, COVID-19, and avian flu. Health Secretary Robert F. Kennedy Jr. justified the move by citing risks associated with mRNA technology and plans to allocate resources to safer vaccine platforms. Experts, including former FDA official Peter Lurie and pediatrician Paul Offit, criticized the decision, warning it could jeopardize future pandemic responses. Kennedy has also made significant changes to U.S. vaccination policies, including removing COVID-19 vaccines for children and pregnant women from CDC recommendations and replacing the entire vaccination advisory committee. The debate highlights contrasting views on mRNA vaccines’ safety and effectiveness, with proponents emphasizing their critical role in combating severe infections and saving lives.
